174 related articles for article (PubMed ID: 19498007)
1. Epigenetic modulation of cancer-germline antigen gene expression in tumorigenic human mesenchymal stem cells: implications for cancer therapy.
Gjerstorff M; Burns JS; Nielsen O; Kassem M; Ditzel H
Am J Pathol; 2009 Jul; 175(1):314-23. PubMed ID: 19498007
[TBL] [Abstract][Full Text] [Related]
2. The histopathology of a human mesenchymal stem cell experimental tumor model: support for an hMSC origin for Ewing's sarcoma?
Burns JS; Abdallah BM; Schrøder HD; Kassem M
Histol Histopathol; 2008 Oct; 23(10):1229-40. PubMed ID: 18712675
[TBL] [Abstract][Full Text] [Related]
3. Tumorigenic heterogeneity in cancer stem cells evolved from long-term cultures of telomerase-immortalized human mesenchymal stem cells.
Burns JS; Abdallah BM; Guldberg P; Rygaard J; Schrøder HD; Kassem M
Cancer Res; 2005 Apr; 65(8):3126-35. PubMed ID: 15833842
[TBL] [Abstract][Full Text] [Related]
4. Adult human mesenchymal stem cell as a target for neoplastic transformation.
Serakinci N; Guldberg P; Burns JS; Abdallah B; Schrødder H; Jensen T; Kassem M
Oncogene; 2004 Jun; 23(29):5095-8. PubMed ID: 15107831
[TBL] [Abstract][Full Text] [Related]
5. Targeted methylation of two tumor suppressor genes is sufficient to transform mesenchymal stem cells into cancer stem/initiating cells.
Teng IW; Hou PC; Lee KD; Chu PY; Yeh KT; Jin VX; Tseng MJ; Tsai SJ; Chang YS; Wu CS; Sun HS; Tsai KD; Jeng LB; Nephew KP; Huang TH; Hsiao SH; Leu YW
Cancer Res; 2011 Jul; 71(13):4653-63. PubMed ID: 21518779
[TBL] [Abstract][Full Text] [Related]
6. Decellularized matrix from tumorigenic human mesenchymal stem cells promotes neovascularization with galectin-1 dependent endothelial interaction.
Burns JS; Kristiansen M; Kristensen LP; Larsen KH; Nielsen MO; Christiansen H; Nehlin J; Andersen JS; Kassem M
PLoS One; 2011; 6(7):e21888. PubMed ID: 21779348
[TBL] [Abstract][Full Text] [Related]
7. Epigenetic regulation of X-linked cancer/germline antigen genes by DNMT1 and DNMT3b.
James SR; Link PA; Karpf AR
Oncogene; 2006 Nov; 25(52):6975-85. PubMed ID: 16715135
[TBL] [Abstract][Full Text] [Related]
8. Long-term cultures of bone marrow-derived human mesenchymal stem cells frequently undergo spontaneous malignant transformation.
Røsland GV; Svendsen A; Torsvik A; Sobala E; McCormack E; Immervoll H; Mysliwietz J; Tonn JC; Goldbrunner R; Lønning PE; Bjerkvig R; Schichor C
Cancer Res; 2009 Jul; 69(13):5331-9. PubMed ID: 19509230
[TBL] [Abstract][Full Text] [Related]
9. Maintenance of differentiation potential of human bone marrow mesenchymal stem cells immortalized by human telomerase reverse transcriptase gene despite [corrected] extensive proliferation.
Abdallah BM; Haack-Sørensen M; Burns JS; Elsnab B; Jakob F; Hokland P; Kassem M
Biochem Biophys Res Commun; 2005 Jan; 326(3):527-38. PubMed ID: 15596132
[TBL] [Abstract][Full Text] [Related]
10. Epigenetic regulation of CD133 and tumorigenicity of CD133+ ovarian cancer cells.
Baba T; Convery PA; Matsumura N; Whitaker RS; Kondoh E; Perry T; Huang Z; Bentley RC; Mori S; Fujii S; Marks JR; Berchuck A; Murphy SK
Oncogene; 2009 Jan; 28(2):209-18. PubMed ID: 18836486
[TBL] [Abstract][Full Text] [Related]
11. Epigenetic remodeling of chromatin architecture: exploring tumor differentiation therapies in mesenchymal stem cells and sarcomas.
Siddiqi S; Mills J; Matushansky I
Curr Stem Cell Res Ther; 2010 Mar; 5(1):63-73. PubMed ID: 19807660
[TBL] [Abstract][Full Text] [Related]
12. Isolation and comparison of mesenchymal stem-like cells from human gastric cancer and adjacent non-cancerous tissues.
Xu X; Zhang X; Wang S; Qian H; Zhu W; Cao H; Wang M; Chen Y; Xu W
J Cancer Res Clin Oncol; 2011 Mar; 137(3):495-504. PubMed ID: 20473524
[TBL] [Abstract][Full Text] [Related]
13. Cancer/Testis Antigens: Expression, Regulation, Tumor Invasion, and Use in Immunotherapy of Cancers.
Salmaninejad A; Zamani MR; Pourvahedi M; Golchehre Z; Hosseini Bereshneh A; Rezaei N
Immunol Invest; 2016 Oct; 45(7):619-40. PubMed ID: 27603913
[TBL] [Abstract][Full Text] [Related]
14. In Vitro Assessment of the Expression and T Cell Immunogenicity of the Tumor-Associated Antigens BORIS, MUC1, hTERT, MAGE-A3 and Sp17 in Uterine Cancer.
Vanderstraeten A; Tuyaerts S; Everaert T; Van Bree R; Verbist G; Luyten C; Amant F
Int J Mol Sci; 2016 Sep; 17(9):. PubMed ID: 27618037
[TBL] [Abstract][Full Text] [Related]
15. Neoplastic transformation by TERT in FGF-2-expanded human mesenchymal stem cells.
Yamaoka E; Hiyama E; Sotomaru Y; Onitake Y; Fukuba I; Sudo T; Sueda T; Hiyama K
Int J Oncol; 2011 Jul; 39(1):5-11. PubMed ID: 21573488
[TBL] [Abstract][Full Text] [Related]
16. Cancer-germline gene expression in pediatric solid tumors using quantitative real-time PCR.
Jacobs JF; Brasseur F; Hulsbergen-van de Kaa CA; van de Rakt MW; Figdor CG; Adema GJ; Hoogerbrugge PM; Coulie PG; de Vries IJ
Int J Cancer; 2007 Jan; 120(1):67-74. PubMed ID: 17019710
[TBL] [Abstract][Full Text] [Related]
17. Correlation between the high expression levels of cancer-germline genes with clinical characteristics in esophageal squamous cell carcinoma.
Chen X; Wang L; Yue D; Liu J; Huang L; Yang L; Cao L; Qin G; Li A; Wang D; Wang M; Qi Y; Zhang B; van der Bruggen P; Zhang Y
Histol Histopathol; 2017 Aug; 32(8):793-803. PubMed ID: 27868181
[TBL] [Abstract][Full Text] [Related]
18. Enhanced expression of cancer testis antigen genes in glioma stem cells.
Yawata T; Nakai E; Park KC; Chihara T; Kumazawa A; Toyonaga S; Masahira T; Nakabayashi H; Kaji T; Shimizu K
Mol Carcinog; 2010 Jun; 49(6):532-44. PubMed ID: 20082319
[TBL] [Abstract][Full Text] [Related]
19. Cancer-germline antigen vaccines and epigenetic enhancers: future strategies for cancer treatment.
Gjerstorff MF; Burns J; Ditzel HJ
Expert Opin Biol Ther; 2010 Jul; 10(7):1061-75. PubMed ID: 20420535
[TBL] [Abstract][Full Text] [Related]
20. Heterogeneous expression of MAGE-A genes in occult disseminated tumor cells: a novel multimarker reverse transcription-polymerase chain reaction for diagnosis of micrometastatic disease.
Kufer P; Zippelius A; Lutterbüse R; Mecklenburg I; Enzmann T; Montag A; Weckermann D; Passlick B; Prang N; Reichardt P; Dugas M; Köllermann MW; Pantel K; Riethmüller G
Cancer Res; 2002 Jan; 62(1):251-61. PubMed ID: 11782385
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
